(Q42698847)

5 November 2017

0 references

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype? (English)

1 reference

5 November 2017

1 reference

1 reference

2

Andrew J Pollard

1 reference

5 November 2017

Anoop S Pulickal

1

1 reference

PubMed ID

17542742

5 November 2017

language of work or name

1 reference

1 June 2007

1 reference

Expert Review of Vaccines

5 November 2017

1 reference

5 November 2017

6

1 reference

5 November 2017

3

1 reference

5 November 2017

293-295

1 reference

Typhoid and paratyphoid fever

5 November 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Typhoid fever in children aged less than 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Immunology of bacterial polysaccharide antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Capsular Vi polysaccharide antigen in Salmonella enterica serovar typhi isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Efficient vaccination strategy against typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Meningococcal polysaccharide-protein conjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Meningococcal conjugate vaccine in adolescents and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Vi-deficient and nonfimbriated mutants of Salmonella typhi agglutinate human blood type antigens and are hyperinvasive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Increasing prevalence of Salmonella enterica serotype Paratyphi-A in patients with enteric fever in a periurban slum setting of Kolkata, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Paratyphoid fever in India: An emerging problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.293

21 January 2018

Identifiers

DOI

10.1586/14760584.6.3.293

1 reference

5 November 2017

1 reference

PubMed ID

17542742